Pursuant to SEBI Operational Circular No. SEBI/HO/DDHS/P/CIR/2021/613 dated August 10, 2021, read with SEBI Circular No. SEBI/HO/DDHS/DDHSRACPODI/P/CIR/2023/049 dated March 31, 2023, Bal Pharma has confirmed that the company is not a Large Corporate as per the applicability criteria mentioned in Chapter XII - Clause 1.2 of the said Operational Circular for the financial year 2023-24. The details required as per Annexure A of the said circular are enclosed.
The above information is a part of company’s filings submitted to BSE.
